These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 16099792

  • 1. Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response.
    Sato T, Nakai T, Tamura N, Okamoto S, Matsuoka K, Sakuraba A, Fukushima T, Uede T, Hibi T.
    Gut; 2005 Sep; 54(9):1254-62. PubMed ID: 16099792
    [Abstract] [Full Text] [Related]

  • 2. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.
    Manousou P, Kolios G, Drygiannakis I, Pyrovolaki K, Bourikas L, Papadaki HA, Kouroumalis E.
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.
    Caruso R, Sarra M, Stolfi C, Rizzo A, Fina D, Fantini MC, Pallone F, MacDonald TT, Monteleone G.
    Gastroenterology; 2009 Jun; 136(7):2270-9. PubMed ID: 19505427
    [Abstract] [Full Text] [Related]

  • 4. T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease.
    Matsuoka K, Inoue N, Sato T, Okamoto S, Hisamatsu T, Kishi Y, Sakuraba A, Hitotsumatsu O, Ogata H, Koganei K, Fukushima T, Kanai T, Watanabe M, Ishii H, Hibi T.
    Gut; 2004 Sep; 53(9):1303-8. PubMed ID: 15306590
    [Abstract] [Full Text] [Related]

  • 5. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells.
    Pizarro TT, Michie MH, Bentz M, Woraratanadharm J, Smith MF, Foley E, Moskaluk CA, Bickston SJ, Cominelli F.
    J Immunol; 1999 Jun 01; 162(11):6829-35. PubMed ID: 10352304
    [Abstract] [Full Text] [Related]

  • 6. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease.
    Kobayashi T, Okamoto S, Hisamatsu T, Kamada N, Chinen H, Saito R, Kitazume MT, Nakazawa A, Sugita A, Koganei K, Isobe K, Hibi T.
    Gut; 2008 Dec 01; 57(12):1682-9. PubMed ID: 18653729
    [Abstract] [Full Text] [Related]

  • 7. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution.
    Heller F, Florian P, Bojarski C, Richter J, Christ M, Hillenbrand B, Mankertz J, Gitter AH, Bürgel N, Fromm M, Zeitz M, Fuss I, Strober W, Schulzke JD.
    Gastroenterology; 2005 Aug 01; 129(2):550-64. PubMed ID: 16083712
    [Abstract] [Full Text] [Related]

  • 8. Quantitation of chemokines (MDC, TARC) expression in mucosa from Crohn's disease and ulcerative colitis.
    Jugde F, Alizadeh M, Boissier C, Chantry D, Siproudhis L, Corbinais S, Quelvennec E, Dyard F, Campion JP, Gosselin M, Bretagne JF, Sémana G, Heresbach D.
    Eur Cytokine Netw; 2001 Aug 01; 12(3):468-77. PubMed ID: 11566628
    [Abstract] [Full Text] [Related]

  • 9. Bioactive IL-18 expression is up-regulated in Crohn's disease.
    Monteleone G, Trapasso F, Parrello T, Biancone L, Stella A, Iuliano R, Luzza F, Fusco A, Pallone F.
    J Immunol; 1999 Jul 01; 163(1):143-7. PubMed ID: 10384110
    [Abstract] [Full Text] [Related]

  • 10. High plasma osteopontin levels in patients with inflammatory bowel disease.
    Mishima R, Takeshima F, Sawai T, Ohba K, Ohnita K, Isomoto H, Omagari K, Mizuta Y, Ozono Y, Kohno S.
    J Clin Gastroenterol; 2007 Feb 01; 41(2):167-72. PubMed ID: 17245215
    [Abstract] [Full Text] [Related]

  • 11. Type 1 T-helper cell predominance in granulomas of Crohn's disease.
    Kakazu T, Hara J, Matsumoto T, Nakamura S, Oshitani N, Arakawa T, Kitano A, Nakatani K, Kinjo F, Kuroki T.
    Am J Gastroenterol; 1999 Aug 01; 94(8):2149-55. PubMed ID: 10445542
    [Abstract] [Full Text] [Related]

  • 12. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.
    Allez M, Tieng V, Nakazawa A, Treton X, Pacault V, Dulphy N, Caillat-Zucman S, Paul P, Gornet JM, Douay C, Ravet S, Tamouza R, Charron D, Lémann M, Mayer L, Toubert A.
    Gastroenterology; 2007 Jun 01; 132(7):2346-58. PubMed ID: 17570210
    [Abstract] [Full Text] [Related]

  • 13. The role of the novel Th17 cytokine IL-26 in intestinal inflammation.
    Dambacher J, Beigel F, Zitzmann K, De Toni EN, Göke B, Diepolder HM, Auernhammer CJ, Brand S.
    Gut; 2009 Sep 01; 58(9):1207-17. PubMed ID: 18483078
    [Abstract] [Full Text] [Related]

  • 14. Osteopontin expression in ulcerative colitis is distinctly different from that in Crohn's disease and diverticulitis.
    Masuda H, Takahashi Y, Asai S, Hemmi A, Takayama T.
    J Gastroenterol; 2005 Apr 01; 40(4):409-13. PubMed ID: 15868372
    [Abstract] [Full Text] [Related]

  • 15. The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity.
    Liu Z, Yadav PK, Xu X, Su J, Chen C, Tang M, Lin H, Yu J, Qian J, Yang PC, Wang X.
    J Leukoc Biol; 2011 Apr 01; 89(4):597-606. PubMed ID: 21227898
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lamina propria c-kit+ immune precursors reside in human adult intestine and differentiate into natural killer cells.
    Chinen H, Matsuoka K, Sato T, Kamada N, Okamoto S, Hisamatsu T, Kobayashi T, Hasegawa H, Sugita A, Kinjo F, Fujita J, Hibi T.
    Gastroenterology; 2007 Aug 01; 133(2):559-73. PubMed ID: 17681176
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.